Chemed Shares Outstanding 2012-2026 | CHE
Chemed shares outstanding history from 2012 to 2026. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- Chemed shares outstanding for the quarter ending March 31, 2026 were 0.014B, a 7.27% decline year-over-year.
- Chemed 2025 shares outstanding were 0.014B, a 4.78% decline from 2024.
- Chemed 2024 shares outstanding were 0.015B, a 0.09% decline from 2023.
- Chemed 2023 shares outstanding were 0.015B, a 0.67% increase from 2022.
|
Chemed Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025 | 14 |
| 2024 | 15 |
| 2023 | 15 |
| 2022 | 15 |
| 2021 | 16 |
| 2020 | 16 |
| 2019 | 17 |
| 2018 | 17 |
| 2017 | 17 |
| 2016 | 17 |
| 2015 | 17 |
| 2014 | 18 |
| 2013 | 19 |
| 2012 | 19 |
| 2011 | 21 |
|
Chemed Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2026-03-31 | 14 |
| 2025-12-31 | 14 |
| 2025-09-30 | 14 |
| 2025-06-30 | 15 |
| 2025-03-31 | 15 |
| 2024-12-31 | 15 |
| 2024-09-30 | 15 |
| 2024-06-30 | 15 |
| 2024-03-31 | 15 |
| 2023-12-31 | 15 |
| 2023-09-30 | 15 |
| 2023-06-30 | 15 |
| 2023-03-31 | 15 |
| 2022-12-31 | 15 |
| 2022-09-30 | 15 |
| 2022-06-30 | 15 |
| 2022-03-31 | 15 |
| 2021-12-31 | 16 |
| 2021-09-30 | 16 |
| 2021-06-30 | 16 |
| 2021-03-31 | 16 |
| 2020-12-31 | 16 |
| 2020-09-30 | 16 |
| 2020-06-30 | 16 |
| 2020-03-31 | 17 |
| 2019-12-31 | 17 |
| 2019-09-30 | 17 |
| 2019-06-30 | 16 |
| 2019-03-31 | 17 |
| 2018-12-31 | 17 |
| 2018-09-30 | 17 |
| 2018-06-30 | 17 |
| 2018-03-31 | 17 |
| 2017-12-31 | 17 |
| 2017-09-30 | 17 |
| 2017-06-30 | 16 |
| 2017-03-31 | 17 |
| 2016-12-31 | 17 |
| 2016-09-30 | 17 |
| 2016-06-30 | 17 |
| 2016-03-31 | 17 |
| 2015-12-31 | 17 |
| 2015-09-30 | 17 |
| 2015-06-30 | 17 |
| 2015-03-31 | 17 |
| 2014-12-31 | 18 |
| 2014-09-30 | 18 |
| 2014-06-30 | 18 |
| 2014-03-31 | 18 |
| 2013-12-31 | 19 |
| 2013-09-30 | 19 |
| 2013-06-30 | 19 |
| 2013-03-31 | 19 |
| 2012-12-31 | 19 |
| 2012-09-30 | 19 |
| 2012-06-30 | 19 |
| 2012-03-31 | 19 |
| 2011-12-31 | 21 |
| 2011-09-30 | 21 |
| 2011-06-30 | 22 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $5.639B | $2.530B |
| Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |